fbpixel

Our website uses cookies to help enhance your browsing experience. Continue to browse our site if you agree to our use of cookies as described in Unilab's Cookie Policy .

For information on how we protect your privacy, please read our Privacy Policy .

Montra
Formulation
Each sustained release capsule contains:
Isosorbide-5-Mononitrate 30 mg or 60 mg

Isosorbide-5-Mononitrate

Montra®

Prescription Drug

Indication

  • Prophylaxis of anginal attacks in patients with chronic stable angina pectoris associated with coronary artery disease

ISMN is NOT indicated for the management of acute attacks of angina pectoris

Dosage and Administration

For more information on safety, precaution and other information about this product, please see the Product Insert.

Please consult your physician and other healthcare providers before taking any prescription medicines found on this site. The contents found on this page are for information purposes only. It should not be construed as a substitute for professional medical advise and should not be relied upon in that regard. You undertake to carefully read all product packaging and labels prior to use.

Caution: Food, Drugs, Devices and Cosmetics Act prohibits dispensing without prescription.